Giant cell hepatitis and autoimmune hemolytic anemia after chickenpox

Turk J Gastroenterol. 2010 Dec;21(4):448-51. doi: 10.4318/tjg.2010.0135.

Abstract

Autoimmune hemolytic anemia with giant cell hepatitis is a distinct entity in children. It is usually fatal with progressive liver disease. Immunosuppressive treatment with conventional drugs offers some response; however, it is usually only temporary. Alternative therapeutic options with monoclonals have been reported with promising remission of the disease. We report a case with autoimmune hemolytic anemia+giant cell hepatitis after varicella infection. She was resistant to standard immunosuppressive combinations, and rescue therapy with rituximab was used. Remission was not achieved with the drug and the child died with septic complication.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic, Autoimmune / drug therapy
  • Anemia, Hemolytic, Autoimmune / pathology*
  • Anemia, Hemolytic, Autoimmune / virology*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Chickenpox / complications*
  • Chickenpox / immunology
  • Fatal Outcome
  • Female
  • Giant Cells / immunology
  • Giant Cells / pathology
  • Hepatitis / drug therapy
  • Hepatitis / pathology*
  • Hepatitis / virology*
  • Humans
  • Immunologic Factors / therapeutic use
  • Infant
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab